A study of 1,386 Norwegian twin pairs found heritability of illicit drug use ranged from 58% to 81% across substances, replicating findings from the US and Australia in a country with much lower drug use rates.
Read this if you want to understand how much of drug use risk is genetic versus environmental.
58-81% heritability for drug use replicated in Norway despite much lower prevalence than US/Australia
What the researchers found
Researchers assessed lifetime use, abuse, and dependence across five illicit drug categories (cannabis, stimulants, opiates, cocaine, psychedelics) in 1,386 young adult Norwegian twin pairs. Only 6.4% reported significant lifetime use (10+ times) of any illicit substance, reflecting Norway's low drug use prevalence.
Despite the low prevalence, twin model fitting consistently found that resemblance between twins was due largely or entirely to genetic factors rather than shared environment. Best-fit models included only genetic and individual-specific environmental effects, with heritability estimates ranging from 58% to 81% across all analyses.
Meaningful abuse/dependence analyses were only possible for cannabis and for any substance combined, as too few twins met criteria for individual substance dependence diagnoses. The genetic findings replicated results previously reported from the US and Australia.
Why it matters
Replicating the heritability of drug use in Norway, a country with very different drug policies and much lower prevalence than the US or Australia, strengthens the conclusion that genetic vulnerability is a robust finding across cultural and legal contexts, not an artifact of specific social environments.
The numbers in context
1,386 twin pairs studied. Only 6.4% reported significant lifetime illicit drug use (10+ times). Heritability estimates: 58-81% across analyses. Best-fit models: genetic + individual environmental factors only (no shared environmental contribution). Replicated US and Australian findings.
How the study worked
Twin study of 1,386 complete young adult twin pairs from the Norwegian Institute of Public Health Twin Panel. Personal interviews assessed lifetime use, DSM-IV abuse/dependence symptoms and diagnoses for five drug categories. Twin model fitting using Mx statistical package compared genetic, shared environmental, and individual environmental contributions.
What this study cannot tell us
The low prevalence of drug use in Norway limited statistical power, particularly for individual substance dependence analyses. Twin studies assume equal environments for identical and fraternal twins. The young adult age of the sample means some participants may not yet have developed substance problems.
How to read the evidence
Large twin study with personal interviews and standard twin modeling methodology. Cross-cultural replication strengthens the genetic findings.
When this study was published
Published in 2006. Genome-wide association studies have since begun identifying specific genetic variants associated with cannabis use and substance use disorders.
The bigger picture
The consistency of heritability findings across countries with vastly different drug use rates and policies suggests that genetic vulnerability to substance use disorders is a fundamental human characteristic, not culturally specific. The absence of shared environmental effects (family, neighborhood) in best-fit models was particularly notable.
Questions still open
- Why did shared environment (family factors) not contribute to twin resemblance in drug use? Do the same specific genetic variants contribute to drug use risk across different cultural contexts?
Common questions
How much of drug addiction risk is genetic?
Does growing up in a low-drug-use country protect against genetic risk?
Read the original research
Illicit psychoactive substance use, abuse and dependence in a population-based sample of Norwegian twins.
Psychological medicine, 36(7), 955-62
Citation
Kendler, Kenneth S; Aggen, Steven H; Tambs, Kristian; Reichborn-Kjennerud, Ted. (2006). Illicit psychoactive substance use, abuse and dependence in a population-based sample of Norwegian twins.. Psychological medicine, 36(7), 955-62.
Explore the wider topic
- Cannabis and Your Cardiovascular System: Heart Risk, Stroke, and What the Research Shows
- Cannabis and Your Heart: What the Cardiovascular Research Shows
- Coughing Up Black Stuff After Quitting Weed: What It Means
- Lung Recovery After Quitting Weed: The Complete Timeline
- Weed and Your Lungs: Recovery Timeline After Quitting
- Quitting Weed as a Woman: Hormones, Cycles, and Recovery
- Cannabis, Weight, and Diet: What Quitting Does to Your Appetite
- Sex After Quitting Weed: What Changes and What Doesn't
- Cannabis and Driving: DUI Laws, Impairment Science, and What You Need to Know
- Weed and Acne: Can Quitting Cannabis Clear Your Skin?
- Weed and Fertility: What Couples Should Know
- Weed and Your Gut: How Cannabis Affects Digestion
- Weed and Your Heart: Cardiovascular Effects and Recovery
- Weed, Testosterone, and Male Health: What the Research Actually Shows